First human trial tests experimental pill for Tough-to-Treat cancers
NCT ID NCT07179081
Summary
This is an early-stage study testing a new oral medication called AL58805 in patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will give increasing doses to 40 participants to find the highest safe amount and see how the body processes the drug. The main goal is to understand the medication's safety profile and identify any side effects before testing whether it can help control cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.